Key result
A second renal sympathetic denervation procedure was evaluated in 27 patients with resistant hypertension, though the truncated abstract does not report the study results.
Why the study?
Does a second percutaneous renal sympathetic denervation improve clinical, echocardiographic, and renal parameters in patients with resistant hypertension who failed a first procedure?
Cohort (n=27)
No
Does a second percutaneous renal sympathetic denervation improve clinical, echocardiographic, and renal parameters in patients with resistant hypertension who failed a first procedure?
This study evaluates the safety and efficacy of a second renal sympathetic denervation procedure in patients with resistant hypertension who failed an initial procedure.
Small observational data on repeat renal denervation should not change practice; leaves open its utility after failed first procedure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kiuchi et al. (2016) conducted a cohort in Resistant hypertension (n=27). Second renal sympathetic denervation (RSD) was evaluated on Safety and effectiveness of RSD for improvement of clinical parameters and reducing damage to the heart and kidneys. A second renal sympathetic denervation procedure was evaluated in 27 patients with resistant hypertension, though the truncated abstract does not report the study results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: